ONCONETIX INC (ONCO:NASDAQ)
$0.6768 -0.0552 (-7.541%)
Analysed ONCONETIX INC (ONCO:NASDAQ) News Sources
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
17-04-2026
yahoo.com
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
09-04-2026
yahoo.com
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy
07-04-2026
yahoo.com
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
02-04-2026
yahoo.com
Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors
31-03-2026
yahoo.com
BC-Most Active Stocks
27-03-2026
yahoo.com
Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration
25-03-2026
yahoo.com
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
23-03-2026
yahoo.com
Realbotix Announces the Sale of Realbotix, LLC Subsidiary to Onconetix
12-02-2026
yahoo.com
Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer
12-02-2026
yahoo.com
What is the current price of ONCONETIX INC (ONCO:NASDAQ)?
The current price of ONCONETIX INC (ONCO:NASDAQ) is $0.6768.
ONCONETIX INC (ONCO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ONCONETIX INC (ONCO:NASDAQ) since the previous trading day is $-0.0552.
ONCONETIX INC (ONCO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ONCONETIX INC (ONCO:NASDAQ) since the previous trading day is -7.541%.
What is the most recent average sentiment score for ONCONETIX INC (ONCO:NASDAQ)?
The most recent average sentiment score for ONCONETIX INC (ONCO:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ONCONETIX INC (ONCO:NASDAQ)?
The most recent sentiment for ONCONETIX INC (ONCO:NASDAQ) is .
SEC-8K** Filing Available For ONCONETIX INC (ONCO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.